Home  // . //  Industries // Health And Life Sciences
 

What We Do

Our innovative thinking and strategic advice helps clients in the payer, provider, digital health, and life sciences sectors realize their most ambitious organizational and operational visions by bridging the gap between their business today and their vision for the future.

At Oliver Wyman, we are focused on creating positive change in healthcare, but we know we can’t do it all ourselves. Together, with today's leading healthcare experts and innovators, we’ve built a community to share and shape ideas that will transform healthcare. We work to ensure industry transformation through generating meaningful client impact, delivering strategic insights, and creating a healthcare system that meets the needs of communities and companies.  

On November 1, 2021, the Huron life sciences strategy consulting team joined Oliver Wyman, allowing us to bring our relentless pursuit of a better way to pharmaceutical, biotechnology, and medical device companies.  Our new colleagues bring the expertise needed to help life sciences companies tackle their most pressing strategic questions, including increasingly complex commercialization and access-related issues.

 

What We Think

Designing A Healthcare System For The Next Decade

Designing A Healthcare System For The Next Decade

Reimagining how healthcare is delivered, paid for, and consumed

Read More
Healthcare in changing climate: Investing in resiliant solutions

Healthcare in changing climate: Investing in resiliant solutions

Nearly half of the negative health consequences of global warming can be abated with targeted investment in vaccines, treatments and technology

Read More

Steps To Improve Provider Performance In Medicare Advantage

Health systems don’t have to flee Medicare Advantage

Read More

Take The Fork In The Road: AI Choices For Healthcare Leaders

Healthcare organizations face some heady decisions as they map out their generative artificial intelligence plan

Read More
Navigating M&A Opportunities Under The Trump Administration

Navigating M&A Opportunities Under The Trump Administration

Shifting regulatory and market dynamics will impact healthcare in 2025

Read More
 Building A Value-Based Care Portfolio In Specialty Care

Building A Value-Based Care Portfolio In Specialty Care

To get a hold of soaring costs, insurers have an opportunity to be more proactive and creative about partnering with specialists on value-based arrangements

Read More
Cell and Gene Therapy Challenge

Cell and Gene Therapy Challenge

How to treat a million patients

Read More

Understanding The Risks And Rewards Of Care At Home

Care at Home is becoming a viable alternative for low-cost, high-quality care

Read More
Cyber Risk Due Diligence — A Game Changer For Healthcare M&A

Cyber Risk Due Diligence — A Game Changer For Healthcare M&A

A cyberattack can amount to a billion-dollar issue. As consolidation continues, leaders must make cybersecurity an integral part of strategy and due diligence

Read More
 

Solutions

Affordability And Quality Impact

There is immense pressure across the entire healthcare landscape to provide higher quality care, improve the patient experience, lower costs, and reduce clinician burnout. Our Affordability and Quality Impact practice has deep expertise across lines of business to help organizations identify cost drivers, find efficiencies, improve quality of care, and more.

 

Who We Are